Clinical Trials Logo

Filter by:
NCT ID: NCT03833843 Completed - Clinical trials for Congenital Heart Disease

Sudden Cardiac Death in Systemic Right Ventricle

STARSII
Start date: September 1, 2018
Phase:
Study type: Observational

In complete transposition of the great arteries (TGA) with previous atrial switch repair, and congenitally corrected transposition of the great arteries (ccTGA), the morphological right ventricle and its tricuspid valve continue to support the systemic circulation. This results in late complications including including sudden death. This retrospective multicentric study aims to evaluate the prevalence of SCD in a contemporary population of patients with a systemic RV and identify specific risk factors for SCD and hemodynamically significant ventricular arrhythmia This registry records demographics, clinical, imaging data, electrophysiological and laboratory of patients with a sRV and a transposition of the great arteries Primary end points are defined by sudden cardiac death, near-miss sudden death, as well as sustained VT requiring defibrillation.

NCT ID: NCT03833661 Completed - Cholangiocarcinoma Clinical Trials

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Start date: March 26, 2019
Phase: Phase 2
Study type: Interventional

The study to evaluate M7824 monotherapy in participants with advanced or metastatic biliary tract cancer (BTC) who failed or were intolerant to first-line (1L) chemotherapy.

NCT ID: NCT03833297 Completed - Liver Diseases Clinical Trials

Monitoring the HePAtological TOXicity of Drugs (HePATOX)

HePATOX
Start date: February 4, 2019
Phase:
Study type: Observational

Several drugs and chemotherapies seem to have an impact on the hepatological system. This study investigates reports of hepatological toxicities, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

NCT ID: NCT03833128 Completed - Clinical trials for Fatty Acid Oxidation Disorders

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

Start date: April 4, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this Phase 1b study is to assess REN001 safety in subjects with fatty acid oxidation disorders.

NCT ID: NCT03833102 Completed - Clinical trials for Staphylococcus Aureus

Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections

PROSAC
Start date: February 21, 2018
Phase:
Study type: Observational

The primary objective is to demonstrate that the risk of S. aureus bacteremia (SAB) is correlated to the RNA III and SprD RNAs expression

NCT ID: NCT03832946 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis (IPF)

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Start date: February 19, 2019
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.

NCT ID: NCT03832920 Completed - Breast Cancer Clinical Trials

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure

ANIBPV
Start date: May 2, 2019
Phase:
Study type: Observational [Patient Registry]

Paravertebral Block (PVB) combined with general anesthesia (GA) is a conventional pain treatment for breast surgery but sometimes failures can occurs. The efficacy of this block has to be evaluated. Also, for the intra-operative analgesic evaluation of this block, it is necessary to measure intra-operative analgesia index. A monitor of nociception for patients under GA, the PhysiodolorisTM device, offers an index for measuring nociceptive inputs during surgery in anesthetized patients : the ANI index (based on the single R-R interval analysis). The purpose of this observational and prospective study is to assess the variations of this ANI index during breast surgery with or without axillary node dissection with a PVB. This will allow us to quantify the analgesic effect of a PVB during GA for unilateral radical breast surgery with or without axillary node dissection.

NCT ID: NCT03832842 Completed - Clinical trials for Implantation of a Veno-arterial or Veno-venous ECMO

Thrombin Generation as a New Test for Anticoagulation Management in Patients With ECMO

ECMOstase
Start date: May 16, 2019
Phase:
Study type: Observational

ECMO (Extracorporeal Membrane Oxygenation) is a circulatory assistance device aiming at maintaining or restoring cardiopulmonary circulation. Complications of this device are mainly hemorrhagic, related to coagulopathy induced by the initial pathology or by the device itself, or thrombotic and ischemic. One of the major challenges is therefore the management of a suitable curative anticoagulation, sufficient to limit the activation of hemostasis du to the ECMO, but reasonable to prevent hemorrhagic complications. To date, there is no standardized and validated protocol for the management of anticoagulation of patients under ECMO. The thrombin generation may be a valuable test to manage anticoagulation of patients with ECMO.

NCT ID: NCT03832647 Completed - Acne Clinical Trials

Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne

Start date: February 18, 2019
Phase: Phase 4
Study type: Interventional

Study to evaluate the anti-acne efficacy of a dermo-cosmetic associated with the fixed combination Adapalene 0.1%/ benzoyl peroxide 2.5% treatment and to demonstrate that the dermo-cosmetic product can improve the local tolerance of the fixed combination Adapalene 0.1%/ benzoyl peroxide 2.5% treatment Multi centre, Randomised, Double blind, Controlled, Parallel (100 subjects per arm), Intra-subject & inter subject comparisons

NCT ID: NCT03832556 Completed - Clinical trials for Neurogenic Para-osteo-arthritis

Comparison Between CT and MRI in Preoperative Evaluation of Neurogenic Myositis Ossificans or Neurogenic Para-osteo-arthritis

MON-IRM
Start date: April 30, 2019
Phase: N/A
Study type: Interventional

The principal objective of the study is to compare between CT and MRI diagnostic performance (sensibility and specificity) in the preoperative assessment of neurogenic para-osteo-arthritis. The second objectives of the study are: - besides the diagnostic performance (sensibility and specificity), to evaluate the imaging par MRI in visual and descriptive manner heterotopic ossification and connection with vascular and nervous structures. - to study the concordance (two by two) of results of preoperative obtained by MRI and by CT and operative reports. - to study the characteristics of patients with discordant findings (two by two) by MRI, CT scan and operative report.